Han satsar på Vironova

En amerikansk finansman och investerare kliver in i Vironovas styrelse, och ska också satsa pengar i det svenska virusforskningsföretaget.

Mot börsen med kassan full

Det norska cancerforskningsföretaget Algeta tar in 35 miljoner US-dollar för att fortsätta utvecklingen av sitt mest lovande cancerprojekt.

Nytt gäng som satsar på öl

Danisco flyttar sin bryggeri och dryckesenzymverksamhet, som också får en ny ledning. Även en bryggerienhet i Shanghai kommer att få ny chef.

Roche sänker budet på Genentech

I juli ifjol var budet 89 dollar per aktie. Då sa Genentechs styrelse nej tack. Nu meddelar läkemedelsjätten att man sänker budet och vänder sig direkt till småägarna.

Grönt ljus för Getinges bolagsköp

Medicinteknikföretaget Getinge har fått godkännande från den amerikanska konkurrensmyndigheten Federal Trade Commission, FTC för köpet av bolaget Datascope Corp. Efter klartecken från amerikanska myndigheter kan den segdragna affären nu slutföras.

Re-painting the big pig-ture

Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.

Go ahead for leg wound study

Tripep starts a phase II-study of their wound healing joint venture project.

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.

Biotage is regrouping

The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.

Vitamin D is mental health aid

Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.

Danisco strengthens its IP team

Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.

Biotech goes white and bright

White biotech could become Denmark's next blossoming business area.

Swedish nanotech crosses the Atlantic

Genovis signs distribution agreement Finnzymes in US.

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Eli Lilly writes biotech fine history

The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

Pharma is a safe market

Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.

LEO Pharma - International Clinical Trial Manager

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.

Danish biorefinery can save US billions

The Danish Inbicon biorefinery process could save the US billions on foreign oil, the organization states.